The particulars: 103 kg · 1,000 kcal. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor…
All questions
Newest first. 5.2k questions across 107 tags.
The specifics, since they change the answer: 1.7 mg · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…
The specifics, since they change the answer: 4 mg · 3 mL · phosphate-buffered diluent. I would rather understand the derivation than memorise the outcome. Two people…
The case in front of me: GL Biochem · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
Setup, so nobody has to ask: 25 °C · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…
Setup, so nobody has to ask: ALT · a GLP-1 receptor agonist. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
Conditions: purity figure · SGN. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the method…
Details up front: hair thinning · four · survodutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
Stated plainly: STEP 1 · dizziness · 2.4 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
The trend is what I care about; individual weeks are obviously noise. I have used one of these for a while and I am considering switching, which requires a reason.…
For reference: JEEP · dulaglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date,…
What I have: mazdutide · 4 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
I would rather spend on verification than on volume. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
What I have: survodutide · Tianjin. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so…
Concretely: TRIUMPH-1 · fatigue. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
Conditions: ecnoglutide · 20 mg/mL. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so…
The case in front of me: survodutide · 7.5 mg. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as…
I am comparing three suppliers on documentation rather than on price. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
This matters because it predicts what a related molecule should do. This is one of those things that everyone repeats and nobody derives. This matters practically,…
What I have: semaglutide · twelve weeks · room temperature. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow…
The specifics, since they change the answer: FLOW · 2 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
The specifics, since they change the answer: PeptideMeter · HJ. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
I have the full paper rather than the abstract, and the supplementary appendix. I have read the obvious sources and they disagree with each other, so I would rather…
I have three data points across nine months, which I hope is enough to see a trend. I have the document in front of me and I can read the numbers. What I cannot do is…